# Alexis Houssou

> Alexis Houssou is a pre-seed investor at HCVC backing Biotechnology and Health Care. See 22 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [HCVC](https://shizune.co/investors/profile/hardwareclub)
- Location: San Francisco, United States
- Total investments: 22
- Last investment: Feb 2026
- Lead investor: 45%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/alexis-houssou/38/57a/4b1
- X (Twitter): https://twitter.com/A_Houssou?lang=en
- Website: https://x.com/A_Houssou
- Facebook: http://www.facebook.com/alexis.houssou

Alexis Houssou is a pre-seed investor at HCVC in San Francisco focused on Biotechnology and Health Care. Alexis Houssou is the managing partner and Co-founder of HCVC and was a Structured Equity VP at BNP Paribas Private Equity. He attended EM Lyon Business School.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 5 | 23% |
| Health Care | 4 | 18% |
| Personal Health | 2 | 9% |
| Mobile | 1 | 5% |
| Cycling | 1 | 5% |

23 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 8 | 36% |
| Seed | 7 | 32% |
| Series A | 2 | 9% |
| Series B | 1 | 5% |
| Series C | 1 | 5% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 6 | 27% |
| United States | 3 | 14% |
| Belgium | 1 | 5% |
| Denmark | 1 | 5% |
| Switzerland | 1 | 5% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Chiral | Next-generation electronics with nanomaterials | $12M | Seed | Feb 05, 2026 |  |
| Kyron.bio | Kyron.bio uses the power of glycan alterations to enable improved protein therapies. | $6.2M | Seed | May 28, 2025 |  |
| Fuse Vectors | Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy. | $5.2M | Pre-Seed | Feb 25, 2025 |  |
| Orakl Oncology | Orakl Oncology is a precision oncology company provides treatment for cancer. | $11.6M | Seed | Dec 03, 2024 |  |
| Cowboy | Cowboy is an e-bike company that creates innovative electric bikes for city riders. It is still transforming the bike and mobility industries, from the point of sale to the point of service. Its mission is to empower riders to map their own paths, as well as the paths of the cities in which they live, through mindful movement that benefitseveryone.Cowboy's electric bikes are simple — there is no gear and no + and - buttons to adjust the motor's power. The company believes riding a bike should be as simple as hopping into the saddle and putting one foot on the peddle. | $4.4M | Venture - Series Unknown | Sep 04, 2024 |  |
| Surge | Surge is an immunological model capable of predicting postoperative infections. The company combines a single-cell assessment of the immune system before surgery with clinical data using a proprietary machine-learning algorithm. By analyzing the millions of immune cells in a small amount of blood, the platform can mimic surgical trauma in a testtube before surgery. | $5.7M | Seed | Mar 27, 2024 |  |
| Chiral | Next-generation electronics with nanomaterials | $3.8M | Pre-Seed | Feb 27, 2024 |  |
| Nūmi | Nūmi mission to redefine health through groundbreaking research making the unparalleled benefits of breast milk accessible to all. | $3.2M | Pre-Seed | Nov 03, 2023 |  |
| Orakl Oncology | Orakl Oncology is a precision oncology company provides treatment for cancer. | $3.2M | Seed | Oct 04, 2023 |  |
| Renaissance Fusion | Renaissance Fusion is a high-temperature superconductor and stellarator company. | $16.3M | Seed | Jan 26, 2023 |  |

10 of 22 investments shown.

## Co-investors
- [Exor Ventures](https://shizune.co/investors/profile/exor-seeds) — VC Fund, 5 deals together
- [Index Ventures](https://shizune.co/investors/profile/index-ventures) — VC Fund, 5 deals together
- [EXOR N.V.](https://shizune.co/investors/profile/exor-s-p-a) — VC Fund, 4 deals together
- [Boutique Venture Partners](https://shizune.co/investors/profile/boutique-venture-partners) — VC Fund, 3 deals together
- [C4 Ventures](https://shizune.co/investors/profile/c4-ventures) — VC Fund, 3 deals together
- [Exor Ventures](https://shizune.co/investors/profile/exor-ventures) — VC Fund, 3 deals together

## About HCVC

VC Fund · Paris, France

HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.

5 contacts available at HCVC.

| Name | Title | Profile |
| --- | --- | --- |
| Alexandre Flamant | Partner | https://shizune.co/investors/profile/alexandre-flamant |
| Alexis Houssou | Founder and Managing Partner | https://shizune.co/investors/profile/alexis-houssou |
| Aymerik Renard | General Partner | https://shizune.co/investors/profile/aymerik-renard |
| Cyril Abiteboul | Venture Partner | https://shizune.co/investors/profile/cyril-abiteboul |
| Jerry Yang | General Partner | https://shizune.co/investors/profile/jerry-j-m-yang |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

## FAQ

### What does Alexis Houssou invest in?

Alexis Houssou invests primarily in Biotechnology, Health Care and Personal Health startups, most often at Pre-Seed and Seed stage. Most of the 22 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Alexis Houssou last invest?

The most recent investment recorded for Alexis Houssou closed in Feb 2026. Shizune tracks 22 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co